Low-Dose Naltrexone in Diseases' Treatment: Global Review

LDN MS and Me - Chris from the UK (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Neurologist Dr Gary Thomas talks about Low Dose Naltrexone (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis

BMC Immunol
24 April 2015
https://pubmed.ncbi.nlm.nih.gov/25906771/

Duration of opioid receptor blockade determines biotherapeutic response

J Clin Gastroenterol
October 2015
https://pubmed.ncbi.nlm.nih.gov/26119823/

Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability

J Clin Gastroenterol
October 2015
https://pubmed.ncbi.nlm.nih.gov/26203498/

Treatment of clinically isolated syndrome with Low Dose Naltrexone

Clin Case Rep Rev
January 2015
http://www.oatext.com/pdf/CCRR-1-161.pdf

Opioid growth factor and low dose naltrexone impair central nervous system infiltration by CD4+T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis

Exp Biol Med (Maywood)
January 2016
http://www.ncbi.nlm.nih.gov/pubmed/26202376

Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use

Am J Emerg Med
August 2017
https://pubmed.ncbi.nlm.nih.gov/28410920/

Could Low-Dose Naltrexone be an Effective Treatment for Hailey-Hailey Disease?

Integ Biomed Sci
19 July 2016
https://www.gratisoa.org/journals/index.php/MML/article/view/1293/957